Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Bates

Showing results (191-200 of 293) with videos related to

Pageof 30
Sort By:
BMC Medical Genomics|November 5, 2020
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscapeTito Fojo, Lyn Huff, Thomas Litman, et al.
Current Problems in Cancer|June 10, 2022
Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbiditiesStacyann Bailey, Qian Wang, Chung Yin Kong, et al.
Molecular Cancer Therapeutics|December 20, 2007
New inhibitors of ABCG2 identified by high-throughput screeningCurtis J Henrich, Robert W Robey, Heidi R Bokesch, et al.
Biochemistry|July 21, 2004
Mutational analysis of ABCG2: role of the GXXXG motifOrsolya Polgar, Robert W Robey, Kuniaki Morisaki, et al.
Cancer Research|September 17, 2005
ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolatesAssaf Shafran, Ilan Ifergan, Eran Bram, et al.
Expert Review of Anticancer Therapy|July 22, 2010
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumorsCliona Grant, Fahd Rahman, Richard Piekarz, et al.
Experimental Cell Research|December 24, 2018
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor modelsAndrew J McDonald, Katherine M Curt, Ruchi P Patel, et al.
Cancer Research|July 5, 2005
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironmentDezheng Dong, Bryce Ko, Peter Baumeister, et al.
Blood|May 3, 2002
Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemiaDorina M van der Kolk, Edo Vellenga, George L Scheffer, et al.
Journal of Biomolecular Screening|February 24, 2006
A high-throughput cell-based assay for inhibitors of ABCG2 activityCurtis J Henrich, Heidi R Bokesch, Michael Dean, et al.
Pageof 30

Showing results (191-200 of 293) with videos related to

Sort By:
Pageof 30
BMC Medical Genomics|November 5, 2020
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscapeTito Fojo, Lyn Huff, Thomas Litman, et al.
Current Problems in Cancer|June 10, 2022
Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbiditiesStacyann Bailey, Qian Wang, Chung Yin Kong, et al.
Molecular Cancer Therapeutics|December 20, 2007
New inhibitors of ABCG2 identified by high-throughput screeningCurtis J Henrich, Robert W Robey, Heidi R Bokesch, et al.
Biochemistry|July 21, 2004
Mutational analysis of ABCG2: role of the GXXXG motifOrsolya Polgar, Robert W Robey, Kuniaki Morisaki, et al.
Cancer Research|September 17, 2005
ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolatesAssaf Shafran, Ilan Ifergan, Eran Bram, et al.
Expert Review of Anticancer Therapy|July 22, 2010
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumorsCliona Grant, Fahd Rahman, Richard Piekarz, et al.
Experimental Cell Research|December 24, 2018
Targeting mitochondrial hexokinases increases efficacy of histone deacetylase inhibitors in solid tumor modelsAndrew J McDonald, Katherine M Curt, Ruchi P Patel, et al.
Cancer Research|July 5, 2005
Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironmentDezheng Dong, Bryce Ko, Peter Baumeister, et al.
Blood|May 3, 2002
Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemiaDorina M van der Kolk, Edo Vellenga, George L Scheffer, et al.
Journal of Biomolecular Screening|February 24, 2006
A high-throughput cell-based assay for inhibitors of ABCG2 activityCurtis J Henrich, Heidi R Bokesch, Michael Dean, et al.
Pageof 30